{"title": "Find a Clinical Trial", "author": null, "url": null, "hostname": null, "description": "Clinical trials are scientific studies in which new treatments - drugs, diagnostic procedures, and other therapies - are tested in patients to determine if they are safe and effective. Search for Dana-Farber clinical trials by cancer type or protocol number.", "sitename": null, "date": "2023-01-01", "cleaned_text": "Combination with Enzalutamide or Abiraterone/Prednisone In Chemotherapy Na\u00efve Subjects with Metastatic Castration Resistant Prostate Cancer](https://www.dana-farber.org/clinical-trials2/detail/21-105/) Trial Description: is a global, multi-center, open-label, randomized phase 1b/2, active-controlled safety and efficacy study of oral administration of tazemetostat in combination with enzalutamide or abiraterone/prednisone (phase 1b) versus enzalutamide or abiraterone/prednisone alone in asymptomatic or mildly symptomatic subjects with progressive, metastatic castration-resistant prostate cancer (mCRPC) who have progressed on either abiraterone acetate, enzalutamide, or apalutamide or who are second generation anti-androgen treatment naive, and who have not received chemotherapy for mCRPC. This study is designed to determine the recommended phase 2 doses (RP2D) of tazemetostat in combination with either enzalutamide or abiraterone/prednisone, based on safety, tolerability, pharmacokinetic, pharmacodynamic, profiles. - Conditions: prostate cancer "}